Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP853217.RA6sExgo9dQnDf8sfnwqHWJgCTJzhiDDrqMhB51DksFh8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP853217.RA6sExgo9dQnDf8sfnwqHWJgCTJzhiDDrqMhB51DksFh8130_assertion type Assertion NP853217.RA6sExgo9dQnDf8sfnwqHWJgCTJzhiDDrqMhB51DksFh8130_head.
- NP853217.RA6sExgo9dQnDf8sfnwqHWJgCTJzhiDDrqMhB51DksFh8130_assertion description "[PMN surface activation and inflammatory markers (i.e., CD14, TF, CD11b, and leukocyte alkaline phosphatase [LAP]) were all significantly higher in ET versus control subjects, with CD14 and LAP being the highest in the JAK2 mutation carriers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP853217.RA6sExgo9dQnDf8sfnwqHWJgCTJzhiDDrqMhB51DksFh8130_provenance.
- NP853217.RA6sExgo9dQnDf8sfnwqHWJgCTJzhiDDrqMhB51DksFh8130_assertion evidence source_evidence_literature NP853217.RA6sExgo9dQnDf8sfnwqHWJgCTJzhiDDrqMhB51DksFh8130_provenance.
- NP853217.RA6sExgo9dQnDf8sfnwqHWJgCTJzhiDDrqMhB51DksFh8130_assertion SIO_000772 17577920 NP853217.RA6sExgo9dQnDf8sfnwqHWJgCTJzhiDDrqMhB51DksFh8130_provenance.
- NP853217.RA6sExgo9dQnDf8sfnwqHWJgCTJzhiDDrqMhB51DksFh8130_assertion wasDerivedFrom befree-20140225 NP853217.RA6sExgo9dQnDf8sfnwqHWJgCTJzhiDDrqMhB51DksFh8130_provenance.
- NP853217.RA6sExgo9dQnDf8sfnwqHWJgCTJzhiDDrqMhB51DksFh8130_assertion wasGeneratedBy ECO_0000203 NP853217.RA6sExgo9dQnDf8sfnwqHWJgCTJzhiDDrqMhB51DksFh8130_provenance.